The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Hims & Hers Health Inc shares valued at $1,091,766 were sold by Okupe Oluyemi on Jun 23 ’25. At $47.25 per share, Okupe Oluyemi sold 23,107 shares. The insider’s holdings dropped to 63,222 shares worth approximately $2.93 million following the completion of this transaction.
Also, Oluyemi Okupe purchased 69,431 shares, netting a total of over 2,914,713 in proceeds.
Before that, Chi Michael had sold 17,102 shares from its account. In a trade valued at $1,021,844, the Chief Commercial Officer traded Hims & Hers Health Inc shares for $59.75 each. Upon closing the transaction, the insider’s holdings decreased to 17,102 shares, worth approximately $12.9 million.
As published in a research note from Needham on June 23, 2025, Hims & Hers Health Inc [HIMS] has been rated down from a Buy to a Hold. Analysts at Needham resumed the stock at ‘”a Buy”‘ outlook in a report released in early June. As of April 29, 2025, TD Cowen has decreased its “Buy” rating to a “Hold” for HIMS. Earlier on February 18, 2025, Morgan Stanley downgraded its rating. Their new recommendation was “an Equal-weight” for HIMS stock which previously was a “an Overweight”.
Analyzing HIMS Stock Performance
On last trading session,, Hims & Hers Health Inc [NYSE: HIMS] rose 11.76% to $46.28. The stock’s lowest price that day was $40.88, but it reached a high of $46.801 in the same session. During the last five days, there has been a drop of approximately -24.22%. Over the course of the year, Hims & Hers Health Inc shares have jumped approximately 108.94%. Shares of the company reached a 52-week high of $72.98 on 02/19/25 and a 52-week low of $23.97 on 04/04/25.
Support And Resistance Levels for Hims & Hers Health Inc (HIMS)
According to the 24-hour chart, there is a support level at 42.51, which, if violated, would cause prices to drop to 38.73. In the upper region, resistance lies at 48.43. The next price resistance is at 50.57. RSI (Relative Strength Index) is 43.34 on the 14-day chart, showing neutral technical sentiment.
Is Hims & Hers Health Inc subject to short interest?
Stocks of Hims & Hers Health Inc saw a sharp steep in short interest on 2025-06-13 dropping by -0.65 million shares to 61.69 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 62.34 million shares. A decline of -1.05% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 1.47 of the overall float, the days-to-cover ratio (short ratio) decline to 1.47.
Which companies own the most shares of Hims & Hers Health Inc (HIMS)?
In terms of Hims & Hers Health Inc share price expectations, FactSet research, analysts set an average price target of 55 in the next 12 months, up nearly 32.82% from the previous closing price of $41.41. Analysts anticipate Hims & Hers Health Inc stock to reach 68 by 2025, with the lowest price target being 30. In spite of this, 13 analysts ranked Hims & Hers Health Inc stock as Buy at the end of 2025. On January 10, 2025, Citigroup assigned a price target of “a Sell” to the stock and downgraded coverage with a $25.
